OPKO Health Inc.
OPK | TA
Overview
Corporate Details
- ISIN(s):
- US68375N1037
- LEI:
- Country:
- Israel
- Address:
- 4400 Biscayne Blvd., 33137 Miami
- Website:
- https://www.opko.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Opko Health operates in the healthcare sector, providing diagnostic products, pharmaceuticals, and innovative medical solutions in Israel.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-10 02:28 |
Director's Dealing
Immediate Report
|
English | 51.5 KB | |
| 2025-08-10 02:28 |
Related Party Transaction
Immediate Report
|
English | 36.3 KB | |
| 2025-08-01 01:34 |
Foreign Filer Report
Report of Periodic or Interim Report
|
English | 36.6 KB | |
| 2025-08-01 01:19 |
Quarterly Report
Immediate Report
|
English | 202.1 KB | |
| 2025-08-01 01:19 |
Foreign Filer Report
Immediate Report
|
English | 36.5 KB | |
| 2025-08-01 01:13 |
Earnings Release
Immediate Report
|
English | 292.7 KB | |
| 2025-08-01 01:13 |
Foreign Filer Report
Immediate Report
|
English | 36.4 KB | |
| 2025-07-26 22:17 |
Report Publication Announcement
Immediate Report
|
English | 162.7 KB | |
| 2025-07-26 22:17 |
Report Publication Announcement
Immediate Report
|
English | 36.4 KB | |
| 2025-07-08 17:09 |
Regulatory News Service
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for …
|
English | 160.7 KB | |
| 2025-07-08 17:09 |
Foreign Filer Report
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for …
|
English | 36.4 KB | |
| 2025-06-25 18:02 |
Report Publication Announcement
to Participate in the 3rd Annual Piper Sandler Virtual Obesity
Symposium
|
English | 118.5 KB | |
| 2025-06-25 18:02 |
Regulatory News Service
to Participate in the 3rd Annual Piper Sandler Virtual Obesity
Symposium
|
English | 36.4 KB | |
| 2025-06-25 18:00 |
Regulatory News Service
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tabl…
|
English | 193.3 KB | |
| 2025-06-25 18:00 |
Foreign Filer Report
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tabl…
|
English | 36.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
CHOSA Oncology AB | Sweden | CHOSA | |
|
Cinclus Pharma Holding AB | Sweden | CINPHA | |
|
Circio Holding ASA | Norway | CRNA | |
|
CIZZLE BIOTECHNOLOGY HOLDINGS PLC | United Kingdom | CIZ | |
|
CLAL Biotechnology Industries Ltd. | Israel | CBI | |
|
Combigene AB | Sweden | COMBI | |
|
Compugen Ltd. | Israel | CGEN | |
|
Corline Biomedical AB | Sweden | CLBIO | |
| CRISM Therapeutics Corporation | Virgin Islands (British) | N/A | ||
|
Curasight A/S | Denmark | CURAS |